Chengzhi Lu

机构：Sichuan University, Tianjin First Center Hospital, West China Hospital of Sichuan University, Tianjin Medical University · ORCID：0000-0002-4546-6395

发表论文 55 篇 · 总被引 556 次 · h-index 9

代表论文

• Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial (2024 · EClinicalMedicine · 被引 26)
• The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle‐aged and elderly population: A nationwide prospective cohort study (2024 · Diabetes Obesity and Metabolism · 被引 17)
• The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus (2025 · Cardiovascular Diabetology · 被引 9)
• Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis (2025 · Basic Research in Cardiology · 被引 8)
• Deubiquitinase OTUD7B stabilizes HNF4α to alleviate pressure overload-induced cardiac hypertrophy by regulating fatty acid oxidation and inhibiting ferroptosis (2025 · Biomarker Research · 被引 8)
• Frailty transitions and risk of chronic kidney disease: insights from the China Health and Retirement Longitudinal Study (2025 · Renal Failure · 被引 7)